US private equity firm CD&R has agreed to French government demands seeking to protect jobs and investment in France. View on ...

Sanofi is now in “exclusive negotiations” with U.S. private equity firm Clayton, Dubilier & Rice (CD&R) to sell a 50% ...

Under the trilateral deal signed by Sanofi, CD&R and the government, Opella will have to pay a €40 million penalty if it ...

French pharmaceutical company Sanofi confirmed on Monday its plans to sell a controlling stake in its consumer health ...

Sanofi, which is joining a growing number of drugmakers shedding consumer related businesses, said Opella had been valued at ...

The proposed sale turned into a real political issue because Opella's products include Doliprane, the best-selling medicine ...

The sale of a French drugmaker to an American group is likely to now go ahead after French Economy Minister Antoine Armand ...

French drugmaker Sanofi's Monday confirmation that it plans to sell a controlling stake in its over-the-counter unit to a US ...

A stake by France-owned Bpifrance and promise of local job retention have allayed political backlash over the sale of ...

France is considering taking a stake in Sanofi's Opella arm, said finance minister Antoine Armand, to allay concerns that the ...

Sanofi and CD&R partner to fuel Opella’s ambitions in consumer healthcareSanofi and CD&R enter exclusive negotiations to transfer a 50% ...

Pour le chercheur Aurélien Bigo, ce budget montre surtout l’inaction climatique du gouvernement en matière de transports, secteur le plus émetteur en France. We use cookies on our website, and similar ...